Intra-arterial catheter guided steroid administration for the treatment of steroid-refractory intestinal GvHD

Leuk Res. 2014 Feb;38(2):184-7. doi: 10.1016/j.leukres.2013.10.024. Epub 2013 Nov 5.

Abstract

Background: Acute gastrointestinal GvHD (GI-aGvHD) refractory to first-line treatment with systemic corticosteroids is resulting in death in the majority of patients. We prospectively assessed the feasibility and efficacy of regional intra-arterial steroid treatment in adult patients with severe (≥ grade III) GI-aGvHD not responding to first-line treatment.

Patients and methods: Patients with more than +++ GI-aGvHD not responding to intravenous methylprednisolone at a dose of 2mg/kg/day were eligible for inclusion. Catheter guided intra-arterial steroid administration (IASA) was performed into the superior and inferior mesenteric artery.

Results: 12 consecutive patients with steroid-refractory grade III GI-aGvHD received IASA as second-line treatment. 83% of patients had gastrointestinal response including four patients (33%) with complete response at 28 days after IASA. 5/12 patients were alive at a median time of 531 days.

Conclusion: Regional treatment of severe GVHD with IASA treatment seems to be a safe and effective second-line treatment for steroid-refractory GI-aGvHD in adult patients.

Keywords: Angiography; Corticosteroids; Graft-versus-host disease; Intra-arterial therapy.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Feasibility Studies
  • Female
  • Glucocorticoids / administration & dosage*
  • Graft vs Host Disease / drug therapy*
  • Graft vs Host Disease / etiology
  • Hematopoietic Stem Cell Transplantation / adverse effects
  • Humans
  • Infusions, Intra-Arterial
  • Intestinal Diseases / drug therapy*
  • Male
  • Methylprednisolone / administration & dosage*
  • Middle Aged
  • Remission Induction
  • Treatment Failure
  • Treatment Outcome
  • Vascular Access Devices

Substances

  • Glucocorticoids
  • Methylprednisolone